Poseida Therapeutics, Inc. Financing Cash Flow
Poseida Therapeutics, Inc. reported Financing Cash Flow of $699.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2024-11-07
- Poseida Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $742.00K, a 95.03% decline year-over-year.
- Poseida Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-06-30 was $0.00.
- Poseida Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-03-31 was -$43.00K, a 103.63% decline year-over-year.
- Poseida Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Poseida Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $16.13M, a 84.66% decline from fiscal 2022.
- Poseida Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $105.16M, a 4076.29% increase from fiscal 2021.
- Poseida Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $2.52M, a 99.20% decline from fiscal 2020.
- Poseida Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2020 was $313.94M, a 91.00% increase from fiscal 2019.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2024-09-30 | $742.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $742.00K derived: sum of 2 quarters · filed 2024-11-07 | $699.00K 10-Q · filed 2024-11-07 | $699.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$43.00K 10-Q · filed 2024-08-05 | -$43.00K derived: sum of 3 quarters · filed 2024-08-05 | $14.90M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-03-31 | -$43.00K 10-Q · filed 2024-05-14 | -$43.00K derived: sum of 2 quarters · filed 2024-05-14 | $14.90M derived: sum of 3 quarters · filed 2024-11-07 | $14.90M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $14.94M derived: sum of 2 quarters · filed 2024-11-07 | $14.94M derived: sum of 3 quarters · filed 2024-11-07 | $16.13M 10-K · filed 2024-03-07 |
| 2023-09-30 | $14.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $14.94M derived: sum of 2 quarters · filed 2024-11-07 | $16.13M 10-Q · filed 2024-11-07 | $16.18M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $1.19M 10-Q · filed 2024-08-05 | $1.24M derived: sum of 3 quarters · filed 2024-08-05 | $77.08M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $1.19M 10-Q · filed 2024-05-14 | $1.24M derived: sum of 2 quarters · filed 2024-05-14 | $77.08M derived: sum of 3 quarters · filed 2024-05-14 | $77.11M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $75.90M derived: sum of 2 quarters · filed 2024-03-07 | $75.93M derived: sum of 3 quarters · filed 2024-03-07 | $105.16M 10-K · filed 2024-03-07 |
| 2022-09-30 | $75.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $75.87M derived: sum of 2 quarters · filed 2023-11-09 | $105.10M 10-Q · filed 2023-11-09 | $105.34M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $29.26M 10-Q · filed 2023-08-08 | $29.50M derived: sum of 3 quarters · filed 2023-08-08 | $31.35M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $29.23M 10-Q · filed 2023-05-09 | $29.47M derived: sum of 2 quarters · filed 2023-05-09 | $31.32M derived: sum of 3 quarters · filed 2023-05-09 | $31.39M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.09M derived: sum of 2 quarters · filed 2023-03-09 | $2.16M derived: sum of 3 quarters · filed 2023-03-09 | $2.52M 10-K · filed 2023-03-09 |
| 2021-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.92M derived: sum of 2 quarters · filed 2022-11-10 | $2.28M 10-Q · filed 2022-11-10 | $2.32M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $427.00K 10-Q · filed 2022-08-11 | $465.00K derived: sum of 3 quarters · filed 2022-08-11 | $206.99M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $360.00K 10-Q · filed 2022-05-12 | $398.00K derived: sum of 2 quarters · filed 2022-05-12 | $206.93M derived: sum of 3 quarters · filed 2022-05-12 | $309.95M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $206.57M derived: sum of 2 quarters · filed 2022-03-10 | $309.60M derived: sum of 3 quarters · filed 2022-03-10 | $313.94M 10-K · filed 2022-03-10 |
| 2020-09-30 | $206.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $309.56M derived: sum of 2 quarters · filed 2021-11-09 | $313.90M 10-Q · filed 2021-11-09 | $313.92M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $103.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $107.37M 10-Q · filed 2021-08-12 | $107.39M derived: sum of 3 quarters · filed 2021-08-12 | $115.25M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $4.35M 10-Q · filed 2021-05-11 | $4.36M derived: sum of 2 quarters · filed 2021-05-11 | $12.22M derived: sum of 3 quarters · filed 2021-05-11 | |
| 2019-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $7.88M derived: sum of 2 quarters · filed 2021-03-11 | $164.37M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $7.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $164.36M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $156.49M 10-Q · filed 2020-08-20 |